118 related articles for article (PubMed ID: 14991533)
21. Growth suppression by a p14(ARF) exon 1beta adenovirus in human tumor cell lines of varying p53 and Rb status.
Saadatmandi N; Tyler T; Huang Y; Haghighi A; Frost G; Borgstrom P; Gjerset RA
Cancer Gene Ther; 2002 Oct; 9(10):830-9. PubMed ID: 12224024
[TBL] [Abstract][Full Text] [Related]
22. Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.
Bar JK; Harłozińska A; Popiela A; Noga L
Tumour Biol; 2001; 22(2):83-91. PubMed ID: 11125280
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of apoptotic index and bcl-2 and p53 expression in epithelial ovarian carcinoma.
Berker B; Dunder I; Ensari A; Cengiz SD; Simsek E
Eur J Gynaecol Oncol; 2002; 23(6):505-10. PubMed ID: 12556092
[TBL] [Abstract][Full Text] [Related]
24. G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder.
Niehans GA; Kratzke RA; Froberg MK; Aeppli DM; Nguyen PL; Geradts J
Br J Cancer; 1999 Jun; 80(8):1175-84. PubMed ID: 10376969
[TBL] [Abstract][Full Text] [Related]
25. Aberrant expression of the Rb pathway proteins in soft tissue sarcomas.
Sabah M; Cummins R; Leader M; Kay E
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):397-403. PubMed ID: 17122635
[TBL] [Abstract][Full Text] [Related]
26. Abnormal expression of p16(INK4a), cyclin D1, cyclin-dependent kinase 4 and retinoblastoma protein in gastric carcinomas.
Kishimoto I; Mitomi H; Ohkura Y; Kanazawa H; Fukui N; Watanabe M
J Surg Oncol; 2008 Jul; 98(1):60-6. PubMed ID: 18484097
[TBL] [Abstract][Full Text] [Related]
27. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional.
Lossaint G; Besnard E; Fisher D; Piette J; Dulić V
Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626
[TBL] [Abstract][Full Text] [Related]
28. Alteration of G2 cell cycle regulators occurs during carcinogenesis of the endometrium.
Tsuda H; Hashiguchi Y; Inoue T; Yamamoto K
Oncology; 2003; 65(2):159-66. PubMed ID: 12931023
[TBL] [Abstract][Full Text] [Related]
29. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression.
Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR
Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical markers of cell cycle control applied to ovarian and primary peritoneal surface epithelial neoplasms: p21(WAF1/CIP1) predicts survival and good response to platinin-based chemotherapy.
Costa MJ; Hansen CL; Walls JE; Scudder SA
Hum Pathol; 1999 Jun; 30(6):640-7. PubMed ID: 10374771
[TBL] [Abstract][Full Text] [Related]
32. Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.
Xu HJ; Quinlan DC; Davidson AG; Hu SX; Summers CL; Li J; Benedict WF
J Natl Cancer Inst; 1994 May; 86(9):695-9. PubMed ID: 8158700
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer.
Saitoh G; Sugio K; Ishida T; Sugimachi K
Oncol Rep; 2001; 8(4):737-43. PubMed ID: 11410775
[TBL] [Abstract][Full Text] [Related]
34. Association of p21, p21 p27 and p21 p53 status to histological subtypes and prognosis in low-stage epithelial ovarian cancer.
Skirnisdottir I; Seidal T
Cancer Genomics Proteomics; 2013; 10(1):27-34. PubMed ID: 23382584
[TBL] [Abstract][Full Text] [Related]
35. Sodium Fluoride Arrests Renal G2/M Phase Cell-Cycle Progression by Activating ATM-Chk2-P53/Cdc25C Signaling Pathway in Mice.
Luo Q; Guo H; Kuang P; Cui H; Deng H; Liu H; Lu Y; Wei Q; Chen L; Fang J; Zuo Z; Deng J; Li Y; Wang X; Zhao L
Cell Physiol Biochem; 2018; 51(5):2421-2433. PubMed ID: 30537743
[TBL] [Abstract][Full Text] [Related]
36. Alteration of cell-cycle regulation in epithelial ovarian cancer.
Nam EJ; Kim YT
Int J Gynecol Cancer; 2008; 18(6):1169-82. PubMed ID: 18298566
[TBL] [Abstract][Full Text] [Related]
37. Reduced expression of retinoblastoma gene product (pRB) and high expression of p53 are associated with poor prognosis in ovarian cancer.
Dong Y; Walsh MD; McGuckin MA; Cummings MC; Gabrielli BG; Wright GR; Hurst T; Khoo SK; Parsons PG
Int J Cancer; 1997 Aug; 74(4):407-15. PubMed ID: 9291430
[TBL] [Abstract][Full Text] [Related]
38. High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.
Deng Y; Jiang L; Wang Y; Xi Q; Zhong J; Liu J; Yang S; Liu R; Wang J; Huang M; Tang C; Su M
Pathol Res Pract; 2016 Apr; 212(4):239-46. PubMed ID: 26920249
[TBL] [Abstract][Full Text] [Related]
39. The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells.
Zhang R; Shi H; Ren F; Zhang M; Ji P; Wang W; Liu C
J Ovarian Res; 2017 Sep; 10(1):60. PubMed ID: 28899430
[TBL] [Abstract][Full Text] [Related]
40. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors.
Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ
Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
